Answers are grounded in this paper and cite their sources.
Conventional pharmaceutical manufacturing relies on fossil fuels and inefficient batch processes, creating significant waste. This review presents a strategy using hydrogen, heterogeneous catalysts, and continuous-flow synthesis for a more sustainable and efficient approach to pharmaceutical manufacturing. We detail two key innovations: first, highly efficient catalysts (Pt/C and polysilane-modified Pd) for atom-economical C─N bond formation. Our flow systems offered superior performance and broad functional group tolerance. Second, we developed a robust polysilane-immobilized Rh-Pt bimetallic catalyst for selective arene hydrogenation under mild conditions. We successfully integrated these technologies into a seamless, multi-step continuous-flow synthesis of donepezil. By successfully integrating these technologies and overcoming challenges like catalyst inhibition, this work demonstrates a highly productive and sustainable process. This approach represents a significant step toward a greener, hydrogen-powered future for chemical manufacturing.
No takes yet. Share an insight, caveat, or question.
Kobayashi et al. (2025) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: